Enterprise Value
1.118B
Cash
652M
Avg Qtr Burn
N/A
Short % of Float
17.45%
Insider Ownership
0.24%
Institutional Own.
92.94%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
MVC-COV1901 Details COVID-19 Vaccine | Approved Update | |
Heplisav-B Details Infectious disease, Hepatitis B vaccine, Hepatitis B | Approved Quarterly sales | |
COVID-19 S-Trimer (with Clover Biopharmaceuticals) Details COVID-19 Vaccine | Approved Quarterly sales | |
CpG 1018 Details COVID-19 | Approved Quarterly sales | |
CpG 1018 Details Plague | Phase 2 Data readout | |
CpG 1018 Details Shingles | Phase 1/2 Initiation | |
VLA2001 Details Infectious disease, COVID-19 | Failed Discontinued |